Loading...

APC anti-mouse CD206 (MMR) Antibody

Pricing & Availability
Clone
C068C2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), MRC1
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
C068C2_APC_1_082911
Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) APC (top) or rat IgG2a, κ APC isotype control (bottom).
  • C068C2_APC_1_082911
    Thioglycollate-elicited BALB/c peritoneal macrophages were surface stained with CD107b (Mac-3) PE, and then intracellularly stained with CD206 (clone C068C2) APC (top) or rat IgG2a, κ APC isotype control (bottom).
  • C068C2_APC_2_082911
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
141707 25 µg 105€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
141708 100 µg 237€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD206, also known as mannose receptor (MR), is a 175 kD type I membrane protein. It is a pattern recognition receptor (PRR) belonging to the C-type lectin superfamily. MR is expressed on macrophages, dendritic cells, Langerhans cells, and hepatic or lymphatic endothelial cells. MR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine through its C-type lectin-like carbohydrate recognition domains, sulfated carbohydrate antigens through its cysteine-rich domain, and collagens through its fibronectin type II domain. MR mediates endocytosis and phagocytosis as well as activation of macrophages and antigen presentation. It plays an important role in host defense and provides a link between innate and adaptive immunity. Recently, MR on lymphatic endothelial cells was found to be involved in leukocyte trafficking and a contributor to the metastatic behavior of cancer cells. It suggests that MR may be a potential target in controlling inflammation and cancer metastasis by targeting the lymphatic vasculature.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Recombinant mouse CD206 (MMR)
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
FC - Verified
Recommended Usage

Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.

Application References
  1. Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
  2. Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
  3. Yang X, et al. 2015. PNAS. 112:2900. PubMed
  4. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  5. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  2. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  3. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  4. Liu C, et al. 2022. Regen Ther. 21:192. PubMed
  5. Miki H, et al. 2020. J Immunol. 204:1892. PubMed
  6. Zhou Y, et al. 2022. Br J Pharmacol. 179:1978. PubMed
  7. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  8. Chang S, et al. 2022. Phytother Res. 36:1678. PubMed
  9. Tu J, et al. 2022. Cancer Sci. 113:2496. PubMed
  10. Wu J, et al. 2023. Bioact Mater. 20:259. PubMed
  11. Poh AR, et al. 2022. Sci Adv. 8:eabl7882. PubMed
  12. Poh AR, et al. 2022. Cell Rep. 41:111479. PubMed
  13. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  14. Lin J, et al. 2022. Eur J Histochem. 67: . PubMed
  15. Sun J, et al. 2023. Mediators Inflamm. 2022:1108569. PubMed
  16. Ye Z, et al. 2023. Front Med (Lausanne). 9:1075465. PubMed
  17. De Schepper S, et al. 2023. Nat Neurosci. 26:406. PubMed
  18. Kimura Y, et al. 2023. Front Immunol. 14:1070196. PubMed
  19. Liang P, et al. 2022. Prostate Cancer Prostatic Dis. 25:539. PubMed
  20. Liu J, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.139. PubMed
  21. Gao T, et al. 2022. Cell Biochem Biophys. 80:579. PubMed
  22. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  23. Song X, et al. 2022. Int J Mol Sci. 23:. PubMed
  24. Wu Y, et al. 2023. Adv Mater. 35:e2210787. PubMed
  25. Sheng Y, et al. 2023. Cancers (Basel). 15:. PubMed
  26. Wang Y, et al. 2023. Front Bioeng Biotechnol. 11:1128268. PubMed
  27. Kaur N, et al. 2023. Heliyon. 9:e14952. PubMed
  28. Lu Y, et al. 2023. J Transl Med. 21:339. PubMed
  29. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  30. Hua, R., Ding, N., et al. 2025. Adv Sci (Weinh). 12(38),e01707. PubMed
  31. Yi, H., Liu, N., et al. 2025. J Cell Commun Signal. 19(4),e70048. PubMed
  32. Wang C, et al. 2018. J Pharmacol Exp Ther. 365:72. PubMed
  33. Hong M, et al. 2021. Int J Mol Sci. 22:. PubMed
  34. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  35. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  36. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  37. Jeong J, et al. 2017. Sci Rep. 7:39848. PubMed
  38. Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed
  39. Liu C, et al. 2019. J Transl Med. 17:300. PubMed
  40. Zhang X, et al. 2017. J Cell Mol Med. 10.1111/jcmm.13329. PubMed
  41. Zhang J, et al. 2021. Front Cardiovasc Med. 8:737652. PubMed
  42. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  43. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  44. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  45. Giordano C, et al. 2014. Hum Mol Genet. . PubMed
  46. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  47. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  48. Tahiri H, et al. 2016. Sci Rep. 6:37391. PubMed
  49. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  50. Chang CF, et al. 2017. Neurobiol Dis. 103:54. PubMed
  51. Pilch Z, et al. 2018. Cancer Immunol Res. 6:930. PubMed
  52. Nawaz A, et al. 2022. Nat Commun. 13:7058. PubMed
  53. Zhang L, et al. 2022. Acta Pharm Sin B. 12:3427. PubMed
  54. Chen X, et al. 2021. Cell Death Differ. 28:1237. PubMed
  55. Trott DW, et al. 2021. Geroscience. 43:1331. PubMed
  56. Yuan Q, et al. 2021. Cell Reports. 34(5):108724. PubMed
  57. Young JA, et al. 2020. Journal of Neuroendocrinology. e12854.. PubMed
  58. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  59. Li S, et al. 2021. Ann Transl Med. 9:1644. PubMed
  60. Chen F, et al. 2022. Evid Based Complement Alternat Med. 2022:1240242. PubMed
  61. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  62. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  63. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  64. Wada N, et al. 2020. Mol Metab. 37:100988. PubMed
  65. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  66. Motoyama S, et al. 2020. Cells. :9. PubMed
  67. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  68. Liao Y, et al. 2020. Mol Ther. 28:855. PubMed
  69. Hu M, et al. 2022. Can Respir J. 2022:5802938. PubMed
  70. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  71. Qiu J, et al. 2016. Sci Rep. 6:39407. PubMed
  72. Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed
  73. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  74. Mariani SA, et al. 2019. Immunity. 50:1439. PubMed
  75. Yan J, et al. 2018. Nat Commun. 9:33. PubMed
  76. Xie Z, et al. 2021. Open Life Sci. 16:653. PubMed
  77. Wu L, et al. 2022. Front Cell Dev Biol. 9:684842. PubMed
  78. Chen X, et al. 2022. J Appl Oral Sci. 30:e20220316. PubMed
  79. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  80. Zhang P, et al. 2022. BMC Med. 20:435. PubMed
  81. Xiao Y, et al. 2022. Clin Transl Med. 12:e1071. PubMed
  82. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  83. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  84. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  85. Taguchi K, et al. 2015. J Urol. . PubMed
  86. Calvo B, et al. 2020. IBRO Rep. 8:36. PubMed
  87. Jin RM, et al. 2017. J Immunol. 198:352. PubMed
  88. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  89. Mallampalli RK, et al. 2021. Front Immunol. 12:735576. PubMed
  90. Taguchi K, et al. 2014. J Am Soc Nephrol. 25:1680. PubMed
  91. Rios-Doria J, et al. 2021. Front Oncol. 10:598477. PubMed
  92. Ayala TS, et al. 2019. Sci Rep. 9:11447. PubMed
  93. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  94. Ganesan R, et al. 2020. FASEB J. 34:15888. PubMed
  95. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  96. Xu Z, et al. 2020. Cancer Immunol Res. 1354:8. PubMed
  97. Xue N, et al. 2017. Sci Rep. 7:39011. PubMed
  98. Lee JY, et al. 2020. Nat Commun. 11:2358. PubMed
  99. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  100. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  101. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  102. Zhou X, et al. 2022. Front Pharmacol. 13:872188. PubMed
  103. Moya-Pérez A, et al. 2015. PLoS One. 10: 0126976. PubMed
  104. De Simone G, et al. 2021. Immunity. :. PubMed
  105. Rhys HI, et al. 2018. EBioMedicine. 29:60. PubMed
  106. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  107. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  108. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  109. Zhang S, et al. 2021. J Inflamm Res. 14:4915. PubMed
  110. Sun M, et al. 2021. J Immunother Cancer. 9:. PubMed
  111. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  112. Blriot C, et al. 2021. Immunity. :. PubMed
  113. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  114. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  115. Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
  116. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  117. Trott DW, et al. 2021. J Physiol. 599:3973. PubMed
  118. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  119. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  120. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  121. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  122. Di Mitri D, et al. 2019. Cell Rep. 28:2156. PubMed
  123. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  124. Remmerie A, et al. 2020. Immunity. 53:641. PubMed
  125. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  126. Guo D, et al. 2022. Bone Res. 10:45. PubMed
  127. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  128. Li ZL, et al. 2021. Mol Ther Nucleic Acids. 25:502. PubMed
  129. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  130. Zhang Y, et al. 2020. Mol Med Rep. 22:534. PubMed
  131. Kiyohara H, et al. 2018. Cell Mol Gastroenterol Hepatol. 7:135. PubMed
  132. Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed
  133. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  134. He H, et al. 2012. Blood. 120:3152. PubMed
  135. Dai K, et al. 2015. J Leukoc Biol. 98: 1071 - 1080. PubMed
  136. Settelmeier S, et al. 2020. PLoS One. 15:e0233261. PubMed
  137. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  138. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  139. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  140. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  141. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  142. Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed
  143. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  144. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  145. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  146. Fang W, et al. 2021. J Exp Clin Cancer Res. 40:4. PubMed
  147. Tang PC, et al. 2022. Adv Sci (Weinh). 9:e2101235. PubMed
  148. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  149. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  150. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  151. Lee SH, et al. 2018. J Exp Med. 215:357. PubMed
  152. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  153. Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
  154. Zhu Y, et al. 2021. Int J Oral Sci. 13:25. PubMed
  155. Filtjens J, et al. 2021. Nat Commun. 12:2936. PubMed
  156. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  157. Canan C, et al. 2014. J Leukoc Biol. 96:473. PubMed
  158. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  159. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  160. Song HY, et al. 2021. Mol Ther. S1525-0016:00472-X. PubMed
  161. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  162. Baardman J et al. 2018. Cell reports. 25(8):2044-2052 . PubMed
  163. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  164. Durga Devi T, et al. 2017. Am J Pathol. 187:2659. PubMed
  165. Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed
  166. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  167. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  168. Ding T, et al. 2021. J Nanobiotechnology. 19:247. PubMed
  169. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  170. Liu Y, et al. 2019. Am J Physiol Cell Physiol. 317:C762. PubMed
  171. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
  172. Nasti A, et al. 2017. Eur J Immunol. 47:2163. PubMed
RRID
AB_10896057 (BioLegend Cat. No. 141707)
AB_10900231 (BioLegend Cat. No. 141708)

Antigen Details

Structure
Type I transmembrane protein, 175 kD, C-type lectin superfamily
Distribution

Macrophages, dendritic cells, Langerhans cells, liver endothelial cells

Function
Pathogen recognition, endocytosis and phagocytosis, antigen presentation
Ligand/Receptor
Antigen containing mannose, fucose, or an N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
Biology Area
Cell Biology, Immunology, Innate Immunity, Signal Transduction
Molecular Family
CD Molecules
Antigen References

1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.

Gene ID
17533 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

Related FAQs

Why is mouse CD206 stained intracellularly and not via surface staining?

Typically, mouse CD206 surface level is relatively low under normal conditions and so intracellular staining protocol is required to get better signal.

Other Formats

View All CD206 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD206 (MMR) C068C2 ICFC,FC
Brilliant Violet 785™ anti-mouse CD206 (MMR) C068C2 ICFC,FC
PE/Dazzle™ 594 anti-mouse CD206 (MMR) C068C2 ICFC,FC
Alexa Fluor® 700 anti-mouse CD206 (MMR) C068C2 ICFC,FC
Spark YG™ 570 anti-mouse CD206 (MMR) C068C2 IHC-F
Biotin anti-mouse CD206 (MMR) C068C2 ICFC,FC
Alexa Fluor® 647 anti-mouse CD206 (MMR) C068C2 ICFC,FC,IHC-F
Alexa Fluor® 488 anti-mouse CD206 (MMR) C068C2 ICFC,FC,IHC-F
APC anti-mouse CD206 (MMR) C068C2 ICFC,FC
PE anti-mouse CD206 (MMR) C068C2 ICFC,FC
FITC anti-mouse CD206 (MMR) C068C2 ICFC,FC
Purified anti-mouse CD206 (MMR) C068C2 ICFC,FC
PerCP/Cyanine5.5 anti-mouse CD206 (MMR) C068C2 ICFC,FC
PE/Cyanine7 anti-mouse CD206 (MMR) C068C2 ICFC,FC
Brilliant Violet 421™ anti-mouse CD206 (MMR) C068C2 ICFC,FC,IHC-F,SB
Brilliant Violet 605™ anti-mouse CD206 (MMR) C068C2 ICFC,FC
Brilliant Violet 650™ anti-mouse CD206 (MMR) C068C2 ICFC,FC
Alexa Fluor® 594 anti-mouse CD206 (MMR) C068C2 IHC-F
PE/Cyanine5 anti-mouse CD206 (MMR) C068C2 ICFC,FC
PE/Fire™ 700 anti-mouse CD206 (MMR) C068C2 ICFC,FC
TotalSeq™-B0173 anti-mouse CD206 (MMR) C068C2 ICPG
Spark Red™ 718 anti-mouse CD206 (MMR) (Flexi-Fluor™) C068C2 FC
Spark Blue™ 574 anti-mouse CD206 (MMR) (Flexi-Fluor™) C068C2 FC
TotalSeq™-C0173 anti-mouse CD206 (MMR) Antibody C068C2 ICPG
Spark YG™ 581 anti-mouse CD206 (MMR) (Flexi-Fluor™) C068C2 FC
Spark YG™ 593 anti-mouse CD206 (MMR) (Flexi-Fluor™) Antibody C068C2 FC
Spark NIR™ 685 anti-mouse CD206 (MMR) (Flexi-Fluor™) Antibody C068C2 FC
Go To Top Version: 3    Revision Date: 04/04/2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account